Abstract 532 Table 1

Family History of Malignancies

ProstateBreastPancreasOvarianOther MalignanciesTotal
VUS Group16 (37%)12 (28%)3 (7%)1 (2%)11 (26%)43
Negative Group33 (51%)15 (23%)4 (6%)5 (8%)8 (12%)65
  • Table 1. Comparison of incidence of prostate, breast, pancreatic, ovarian, and other malignancies in the VUS group and the negative group